COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,164 Articles (22,703 medRxiv, 8,461 bioRxiv)

Most recent first Previous |  Page 1067: Articles 10661-10670  | Next

The T cell receptor repertoire reflects the dynamics of the immune response to vaccination
Mohammed, K., Meadows, A., Hatem, S., Simon, V., Jayaprakash, A. D., Sachidanandam, R.
10.1101/2021.12.09.471735 — Posted: 2021-12-12
Reduced Odds of SARS-CoV-2 Reinfection after Vaccination among New York City Adults, June-August 2021
Levin-Rector, A., Firestein, L., McGibbon, E., Sell, J., Lim, S., Lee, E. H., Weiss, D., Geevarughese, A., Zucker, J. R., Greene, S. K.
10.1101/2021.12.09.21267203 — Posted: 2021-12-11
(SARS-CoV-2) COVID 19: Genomic surveillance and evaluation of the impact on the population speaker of indigenous language in Mexico
Medel Ramirez, C., Medel-Lopez, H., Lara-Merida, J.
10.1101/2021.12.09.21267022 — Posted: 2021-12-11
Emotional Distress, Stress, Anxiety and the Impact of the COVID-19 Pandemic on Early Career Women in Healthcare Sciences Research
Bittar, N., Cohee, A. A., Savoy, A., Ismail, H. M.
10.1101/2021.12.09.21267476 — Posted: 2021-12-11
Serum levels of specialised pro-resolving molecule pathways are greatly increased in SARS-CoV-2 patients and correlate with markers of the adaptive immune response.
Turnbull, J., Jha, R., Ortori, C. A., Lunt, E., Tighe, P. J., Irving, W. L., Gohir, S. A., Kim, D.-H., Valdes, A. M., Tarr, A. W., Barrett, D. A., Chapman, V.
10.1101/2021.12.07.21267409 — Posted: 2021-12-11
NIH Funding of COVID-19 Research in 2020: a Cross Sectional Study
Balaguru, L., Dun, C., Meyer, A., Hennayake, S., Walsh, C., Kung, C., Cary, B., Migliarese, F., Dai, T., Bai, G., Sutcliffe, K., Makary, M. A.
10.1101/2021.12.08.21267482 — Posted: 2021-12-11
A Phenome Wide Association Study of Severe COVID-19 Genetic Risk Variants
Regan, J. A., Abdulrahim, J., Bihlmeyer, N., Haynes, C., Kwee, L. C., Patel, M., Shah, S. H.
10.1101/2021.12.08.21267433 — Posted: 2021-12-11
Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent but clinically inapparent in cancer patients under immune checkpoint therapy
Walle, T., Bajaj, S., Kraske, J. A., Roesner, T., Cussigh, C. S., Kaelber, K. A., Mueller, L. J., Strobel, S. B., Burghaus, J., Kallenberger, S., Stein-Thoeringer, C., Jenzer, M., Schubert, A., Kahle, S., Williams, A., Hoyler, B., Zielske, L., Skatula, R., Sawall, S., Leber, M. F., Kunes, R. Z., Krisam, J., Fremd, C., Schneeweiss, A., Krauss, J., Berger, A. K., Haag, G. M., Zschaebitz, S., Halama, N., Springfeld, C., Kirsten, R., Hassel, J. C., Jaeger, D., NCT ANTICIPATE Investigators, , Ungerechts, G.
10.1101/2021.12.08.21267430 — Posted: 2021-12-11
COVID-19 booster vaccine attitudes and behaviors among university students and staff: the USC Trojan Pandemic Research Initiative
Lee, R. C., Hu, H., Kawaguchi, E. S., Kim, A. E., Soto, D. W., Shanker, K., Klausner, J. D., Van Orman, S., Unger, J. B.
10.1101/2021.12.09.21267545 — Posted: 2021-12-11
Down-regulation of SARS-CoV-2 neutralizing antibodies in vaccinated smokers
Zhang, J., Teng, F., Zhang, X., Wang, H., Liang, T., Guo, S.-B., yu, x.
10.1101/2021.12.09.21267349 — Posted: 2021-12-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).